News | October 11, 2021
Sai Life Sciences presents its midterm report
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as populations continue to age
Assam is home to more than 1,700 species of medicinal plants
Barbara Engelhardt moves her computational and statistics lab to Gladstone
In March it launched its first plastic-free toothbrush packaging, which included Sensodyne Pronamel and parodontax brushes in the US. Asia Pacific rollout of this commenced in Australia
The study is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes.
Union Minister addresses the 13th CII Global MedTech Summit on the sunrise medical devices sector in India
Researchers at the Feinstein Institutes administer extra vaccine doses as part of the NIH funded study
_256_384.jpeg)
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
Self-collection devices designed for ease of use and safety
Subscribe To Our Newsletter & Stay Updated
